Nicole Basta: Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026
Nicole Basta, Associate Professor of Epidemiology at McGill University, shared a post on LinkedIn about a paper by Jake Scott et al. published in NEJM:
“Wondering if it’s worth it to get a Flu, COVID-19, and/or RSV shot this year?
We did the research, so you don’t have to! And the answer is – Yes, it’s worth it!
Our review of over 500 of the most recently published studies revealed important benefits of these vaccines, including:
- Flu vaccination can reduce the risk of hospitalization by nearly 70% in children and by about 50% in adults, including adults 65 yrs and older (with high-dose vaccine).
- COVID-19 vaccination can reduce the risk of hospitalization by about half among all adults, including older adults. Adults with immunocompromising conditions can also benefit with the risk of hospitalization reduced by just under 40%.
- RSV vaccination during pregnancy can reduce the risk of hospitalization for infants by 70%; Similar reduction in risk for vaccinated older adults, as well.
The safety profiles for each of these vaccines continue to demonstrate that serious adverse events are very, very rare.
Check out all of the details for yourself NEJM Group.”
Title: Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026
Authors: Jake Scott, Michael S. Abers, Harleen K. Marwah, Nicole C. McCann, Eric A. Meyerowitz, Aaron Richterman, Derek F. Fleming, Elise J. Holmes, Leah E. Moat, Sydney G. Redepenning, Emily A. Smith, Clare J. Stoddart, Maria E. Sundaram, Angela K. Ulrich, Christopher Alba, Cory J. Anderson, Meredith K. Arpey, Ethan Borre, Joseph Ladines-Lim, Angela J. Mehr, Katherine Rich, Corey Watts, Nicole E. Basta, Jana Jarolimova, Rochelle P. Walensky, Caitlin M. Dugdale

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 11, 2025, 16:16AI Model Predicts Pregnancy Outcomes Through Endometrial Receptivity Scoring – Future Fertility
-
Dec 11, 2025, 15:55Houssein El Hajj: Training Without Borders: Mobility and Opportunity in Gynaecologic Oncology
-
Dec 11, 2025, 15:46Updated ENGOT Website Improves Navigation of European Gynecologic Cancer Research – ENGOT
-
Dec 11, 2025, 15:31Silvia Vicenzi: From a Hormone-Centric Model to an Immune-Centric Understanding of Endometriosis
-
Dec 11, 2025, 15:23Rahul Gajbhiye: Call for Papers – Successful Pregnancies in Patients With Endometriosis
-
Dec 11, 2025, 14:512024 National Patient Survey Insights from 1,500 Fertility Patients – HFEA
-
Dec 11, 2025, 14:27New ASRM/CFAS Conference Targets the Evolving Business Landscape of Reproductive Medicine – ASRM
-
Dec 11, 2025, 02:54Laura Lindberg: Addressing Stigma in Emergency Contraception Awareness
-
Dec 11, 2025, 02:51Vitamin K Shot Refusal Sees Alarming Rise Among Newborns – Unbiased Science
